Charuluxananan S, Kyokong O, Somboonviboon W, Balmongkon B, Chaisomboonpan S
Department of Anesthesiology and Clinical Epidemiology Unit, Faculty of Medicine, Chulalongkorn University, Rama IV Rd., Patumwan, Bangkok 10330, Thailand.
J Anesth. 2000 Apr 25;14(2):77-81. doi: 10.1007/s005400050071.
The aim of this study was to compare the efficacy of nicardipine and lidocaine in attenuation of cardiovascular responses to endotracheal intubation.
In a randomized, double-blind, controlled trial, 60 unpremedicated (ASA I) patients undergoing elective surgery were given either 30 microg.kg(-1) nicardipine or 1.5 mg.kg(-1) lidocaine intravenously 2 min before intubation. Laryngoscopy and tracheal intubation were performed 1 min after induction of anesthesia with 5 mg.kg(-1) thiopentone, followed by administration of 1.5 mg.kg(-1) succinylcholine intravenously. Blood pressure and heart rate were monitored at baseline and every minute until 4 min after intubation. Repeated-measures ANOVA, Student's t test, the chi-square test, and 95% confidence intervals were used as appropriate. P < 0.05 was considered statistically significant.
Baseline hemodynamic variables were not different between the groups. After administration of either agents, diastolic blood pressure and mean blood pressure were significantly lower in the nicardipine group. The heart rate in the nicardipine group was significantly higher. The mean between-group differences in diastolic blood pressure, mean blood pressure, heart rate, and rate-pressure product at baseline and 1 min after starting laryngoscopy were statistically significant.
Nicardipine can be used as an alternative to lidocaine in attenuation of cardiovascular response to tracheal intubation in patients without ischemic heart disease.
本研究旨在比较尼卡地平和利多卡因减轻气管插管心血管反应的疗效。
在一项随机、双盲、对照试验中,60例未接受术前用药(ASA I级)的择期手术患者在插管前2分钟静脉给予30μg·kg⁻¹尼卡地平或1.5mg·kg⁻¹利多卡因。用5mg·kg⁻¹硫喷妥钠诱导麻醉1分钟后进行喉镜检查和气管插管,随后静脉给予1.5mg·kg⁻¹琥珀酰胆碱。在基线时以及插管后每分钟监测血压和心率,直至插管后4分钟。根据情况使用重复测量方差分析、学生t检验、卡方检验和95%置信区间。P<0.05被认为具有统计学意义。
两组间基线血流动力学变量无差异。给予任何一种药物后,尼卡地平组的舒张压和平均血压显著降低。尼卡地平组的心率显著升高。在基线时以及喉镜检查开始后1分钟,两组间舒张压、平均血压、心率和率压乘积的平均差异具有统计学意义。
在无缺血性心脏病患者中,尼卡地平可作为利多卡因的替代品用于减轻气管插管的心血管反应。